Stocks
Editas Medicine (EDIT) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -7.62 | -27.7 | -6.39 | -0.98 | -2.96 | -1.62 | ||
| Changes by years, y/y, % | +18% | +263% | -77% | -85% | +202% | -14.5% | |||
Editas Medicine. EV/EBITDA
Editas Medicine. EV/EBITDA, changes, %
Editas Medicine (EDIT) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -1.09 | -3.26 | -1.91 | -0.69 | -0.25 | -1.62 | |
| Changes by years, y/y, % | -52% | +232% | +216% | +3% | -77% | |||
| Changes by quarters, q/q, % | +61% | +200% | -41% | -64% | -64% | |||
